361 related articles for article (PubMed ID: 33538125)
1. Cancer-associated-platelet-inspired nanomedicines for cancer therapy.
Geranpayehvaghei M; Dabirmanesh B; Khaledi M; Atabakhshi-Kashi M; Gao C; Taleb M; Zhang Y; Khajeh K; Nie G
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1702. PubMed ID: 33538125
[TBL] [Abstract][Full Text] [Related]
2. Bioinspired and Biomimetic Nanomedicines.
Chen Z; Wang Z; Gu Z
Acc Chem Res; 2019 May; 52(5):1255-1264. PubMed ID: 30977635
[TBL] [Abstract][Full Text] [Related]
3. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
Raghunathan S; Rayes J; Sen Gupta A
J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
[TBL] [Abstract][Full Text] [Related]
4. Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy.
Zhang Y; Liu G; Wei J; Nie G
Front Med; 2018 Dec; 12(6):667-677. PubMed ID: 29619757
[TBL] [Abstract][Full Text] [Related]
5. Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.
Xu XR; Zhang D; Oswald BE; Carrim N; Wang X; Hou Y; Zhang Q; Lavalle C; McKeown T; Marshall AH; Ni H
Crit Rev Clin Lab Sci; 2016 Dec; 53(6):409-30. PubMed ID: 27282765
[TBL] [Abstract][Full Text] [Related]
6. Polyprodrug Nanomedicines: An Emerging Paradigm for Cancer Therapy.
Yang K; Yang Z; Yu G; Nie Z; Wang R; Chen X
Adv Mater; 2022 Feb; 34(6):e2107434. PubMed ID: 34693571
[TBL] [Abstract][Full Text] [Related]
7. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
Xu XR; Yousef GM; Ni H
Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor-platelet interplay and micro tumor thrombi during hematogenous tumor metastasis.
Shi Q; Ji T; Tang X; Guo W
Cell Oncol (Dordr); 2023 Jun; 46(3):521-532. PubMed ID: 36652166
[TBL] [Abstract][Full Text] [Related]
9. Beyond the thrombus: Platelet-inspired nanomedicine approaches in inflammation, immune response, and cancer.
Desai C; Koupenova M; Machlus KR; Sen Gupta A
J Thromb Haemost; 2022 Jul; 20(7):1523-1534. PubMed ID: 35441793
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
Kwon S; Ko H; You DG; Kataoka K; Park JH
Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
[TBL] [Abstract][Full Text] [Related]
11. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
12. The prospects of microphysiological systems in modeling platelet pathophysiology in cancer.
Ghosh LD; Jain A
Platelets; 2023 Dec; 34(1):2247489. PubMed ID: 37610007
[TBL] [Abstract][Full Text] [Related]
13. Tumor vasculature-targeting nanomedicines.
Zhang Y; He J
Acta Biomater; 2021 Oct; 134():1-12. PubMed ID: 34271167
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
15. Diethyldithiocarbamate-copper nanocomplex reinforces disulfiram chemotherapeutic efficacy through light-triggered nuclear targeting.
Ren L; Feng W; Shao J; Ma J; Xu M; Zhu BZ; Zheng N; Liu S
Theranostics; 2020; 10(14):6384-6398. PubMed ID: 32483459
[TBL] [Abstract][Full Text] [Related]
16. Platelet-promoting drug delivery efficiency for inhibition of tumor growth, metastasis, and recurrence.
Li X; Hu L; Tan C; Wang X; Ran Q; Chen L; Li Z
Front Oncol; 2022; 12():983874. PubMed ID: 36276066
[TBL] [Abstract][Full Text] [Related]
17. Advancement of platelet-inspired nanomedicine.
Wang S; Yuan J; Yang J; Li N; Liu R; Luan J; Ye D
Platelets; 2018 Nov; 29(7):690-694. PubMed ID: 29883255
[TBL] [Abstract][Full Text] [Related]
18. Nanotechnology and primary hemostasis: Differential effects of nanoparticles on platelet responses.
Matus MF; Vilos C; Cisterna BA; Fuentes E; Palomo I
Vascul Pharmacol; 2018 Feb; 101():1-8. PubMed ID: 29174014
[TBL] [Abstract][Full Text] [Related]
19. The platelet contribution to cancer progression.
Bambace NM; Holmes CE
J Thromb Haemost; 2011 Feb; 9(2):237-49. PubMed ID: 21040448
[TBL] [Abstract][Full Text] [Related]
20. Involvement of platelets in tumor cell metastasis.
Tesfamariam B
Pharmacol Ther; 2016 Jan; 157():112-9. PubMed ID: 26615781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
